Abbott Laboratories (LON:0Q15)

Market Cap	185.12B
Revenue (ttm)	33.51B
Net Income (ttm)	10.71B
Shares Out	n/a
EPS (ttm)	6.10
PE Ratio	17.29
Forward PE	n/a
Dividend	1.77 (1.36%)
Ex-Dividend Date	Jan 15, 2025

Volume	2,430
Average Volume	4,237
Open	131.83
Previous Close	132.92
Day's Range	131.83 - 135.26
52-Week Range	104.15 - 121.60
Beta	0.66
RSI	73.46
Earnings Date	Apr 16, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.40 billion, an increase of 135.08%.

Financial numbers in USD